Amicus Therapeutics IncNASDAQ:FOLD
- LAST PRICE12.1800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 12.1800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FOLD |
|---|---|---|
| 09:32 ET | 31715 | 10.7 |
| 09:34 ET | 15165 | 10.71 |
| 09:36 ET | 13863 | 10.89 |
| 09:38 ET | 34740 | 10.97 |
| 09:39 ET | 13683 | 10.88 |
| 09:41 ET | 12650 | 10.94 |
| 09:43 ET | 34213 | 11.03 |
| 09:45 ET | 45029 | 11.015 |
| 09:48 ET | 24934 | 11.02 |
| 09:50 ET | 67625 | 11.02 |
| 09:52 ET | 24623 | 11.07 |
| 09:54 ET | 5800 | 11.045 |
| 09:56 ET | 16931 | 11.06 |
| 09:57 ET | 15495 | 11.05 |
| 09:59 ET | 21969 | 11.07 |
| 10:01 ET | 23852 | 11.11 |
| 10:03 ET | 11100 | 11.11 |
| 10:06 ET | 14497 | 11.1 |
| 10:08 ET | 15974 | 11.06 |
| 10:10 ET | 27190 | 11.095 |
| 10:12 ET | 32957 | 11.14 |
| 10:14 ET | 6978 | 11.17 |
| 10:15 ET | 9002 | 11.12 |
| 10:17 ET | 8403 | 11.115 |
| 10:19 ET | 29108 | 11.17 |
| 10:21 ET | 12969 | 11.19 |
| 10:24 ET | 3451 | 11.16 |
| 10:26 ET | 15662 | 11.1525 |
| 10:28 ET | 39299 | 11.16 |
| 10:30 ET | 6725 | 11.16 |
| 10:32 ET | 19510 | 11.195 |
| 10:33 ET | 14195 | 11.24 |
| 10:35 ET | 21534 | 11.26 |
| 10:37 ET | 9822 | 11.245 |
| 10:39 ET | 8924 | 11.25 |
| 10:42 ET | 22708 | 11.245 |
| 10:44 ET | 7440 | 11.2 |
| 10:46 ET | 7130 | 11.19 |
| 10:48 ET | 10174 | 11.23 |
| 10:50 ET | 2894 | 11.195 |
| 10:51 ET | 32293 | 11.205 |
| 10:53 ET | 132482 | 11.1925 |
| 10:55 ET | 14786 | 11.195 |
| 10:57 ET | 15991 | 11.2 |
| 11:00 ET | 10326 | 11.205 |
| 11:02 ET | 17598 | 11.225 |
| 11:04 ET | 11237 | 11.25 |
| 11:06 ET | 27967 | 11.28 |
| 11:08 ET | 10335 | 11.27 |
| 11:09 ET | 5870 | 11.28 |
| 11:11 ET | 11108 | 11.3 |
| 11:13 ET | 20079 | 11.305 |
| 11:15 ET | 22827 | 11.325 |
| 11:18 ET | 16752 | 11.31 |
| 11:20 ET | 11746 | 11.3 |
| 11:22 ET | 25543 | 11.27 |
| 11:24 ET | 23640 | 11.275 |
| 11:26 ET | 9892 | 11.285 |
| 11:27 ET | 14480 | 11.285 |
| 11:29 ET | 11860 | 11.275 |
| 11:31 ET | 11642 | 11.325 |
| 11:33 ET | 3477 | 11.315 |
| 11:36 ET | 8915 | 11.36 |
| 11:38 ET | 36018 | 11.4394 |
| 11:40 ET | 42650 | 11.5 |
| 11:42 ET | 61945 | 11.55 |
| 11:44 ET | 41637 | 11.65 |
| 11:45 ET | 26330 | 11.6 |
| 11:47 ET | 8876 | 11.605 |
| 11:49 ET | 10208 | 11.605 |
| 11:51 ET | 20030 | 11.6062 |
| 11:54 ET | 54267 | 11.69 |
| 11:56 ET | 102157 | 11.78 |
| 11:58 ET | 41900 | 11.8 |
| 12:00 ET | 60304 | 11.925 |
| 12:02 ET | 49649 | 11.9 |
| 12:03 ET | 62341 | 11.94 |
| 12:05 ET | 36687 | 11.955 |
| 12:07 ET | 17912 | 11.97 |
| 12:09 ET | 20714 | 11.88 |
| 12:12 ET | 29261 | 11.78 |
| 12:14 ET | 12940 | 11.8001 |
| 12:16 ET | 11902 | 11.7409 |
| 12:18 ET | 34650 | 11.77 |
| 12:20 ET | 8600 | 11.79 |
| 12:21 ET | 16173 | 11.78 |
| 12:23 ET | 16047 | 11.83 |
| 12:25 ET | 16044 | 11.86 |
| 12:27 ET | 48078 | 11.915 |
| 12:30 ET | 20757 | 11.955 |
| 12:32 ET | 19641 | 11.94 |
| 12:34 ET | 41496 | 11.975 |
| 12:36 ET | 51881 | 11.975 |
| 12:38 ET | 41534 | 12.02 |
| 12:39 ET | 16764 | 12.025 |
| 12:41 ET | 29942 | 11.99 |
| 12:43 ET | 33860 | 12.03 |
| 12:45 ET | 43741 | 12.08 |
| 12:48 ET | 28808 | 12.0699 |
| 12:50 ET | 21608 | 12.075 |
| 12:52 ET | 18812 | 12.055 |
| 12:54 ET | 37215 | 12.09 |
| 12:56 ET | 37505 | 12.105 |
| 12:57 ET | 14983 | 12.125 |
| 12:59 ET | 30981 | 12.125 |
| 01:01 ET | 37761 | 12.155 |
| 01:03 ET | 32300 | 12.15 |
| 01:06 ET | 15392 | 12.14 |
| 01:08 ET | 42771 | 12.205 |
| 01:10 ET | 26097 | 12.23 |
| 01:12 ET | 28145 | 12.235 |
| 01:14 ET | 25499 | 12.28 |
| 01:15 ET | 31028 | 12.295 |
| 01:17 ET | 88880 | 12.465 |
| 01:19 ET | 253075 | 12.43 |
| 01:21 ET | 73860 | 12.525 |
| 01:24 ET | 44229 | 12.57 |
| 01:26 ET | 101810 | 12.63 |
| 01:28 ET | 52562 | 12.6308 |
| 01:30 ET | 22008 | 12.58 |
| 01:32 ET | 25496 | 12.64 |
| 01:33 ET | 17887 | 12.6368 |
| 01:35 ET | 28264 | 12.675 |
| 01:37 ET | 16777 | 12.63 |
| 01:39 ET | 29216 | 12.5309 |
| 01:42 ET | 22028 | 12.555 |
| 01:44 ET | 29853 | 12.595 |
| 01:46 ET | 23550 | 12.53 |
| 01:48 ET | 14284 | 12.5 |
| 01:50 ET | 9158 | 12.5206 |
| 01:51 ET | 10022 | 12.46 |
| 01:53 ET | 15508 | 12.465 |
| 01:55 ET | 22803 | 12.42 |
| 01:57 ET | 9738 | 12.46 |
| 02:00 ET | 17494 | 12.45 |
| 02:02 ET | 8836 | 12.445 |
| 02:04 ET | 21786 | 12.3985 |
| 02:06 ET | 20730 | 12.375 |
| 02:08 ET | 25819 | 12.3913 |
| 02:09 ET | 11836 | 12.38 |
| 02:11 ET | 8914 | 12.36 |
| 02:13 ET | 11259 | 12.37 |
| 02:15 ET | 7150 | 12.375 |
| 02:18 ET | 5142 | 12.36 |
| 02:20 ET | 5482 | 12.385 |
| 02:22 ET | 15931 | 12.41 |
| 02:24 ET | 11093 | 12.395 |
| 02:26 ET | 7637 | 12.39 |
| 02:27 ET | 10583 | 12.375 |
| 02:29 ET | 16278 | 12.34 |
| 02:31 ET | 15750 | 12.35 |
| 02:33 ET | 5741 | 12.335 |
| 02:36 ET | 13925 | 12.365 |
| 02:38 ET | 16650 | 12.34 |
| 02:40 ET | 14201 | 12.375 |
| 02:42 ET | 8942 | 12.425 |
| 02:44 ET | 3714 | 12.425 |
| 02:45 ET | 13590 | 12.42 |
| 02:47 ET | 5072 | 12.425 |
| 02:49 ET | 2699 | 12.42 |
| 02:51 ET | 10849 | 12.38 |
| 02:54 ET | 14205 | 12.36 |
| 02:56 ET | 4681 | 12.37 |
| 02:58 ET | 5626 | 12.35 |
| 03:00 ET | 1300 | 12.355 |
| 03:02 ET | 11176 | 12.35 |
| 03:03 ET | 15331 | 12.285 |
| 03:05 ET | 69357 | 12.31 |
| 03:07 ET | 6335 | 12.335 |
| 03:09 ET | 7833 | 12.29 |
| 03:12 ET | 15160 | 12.265 |
| 03:14 ET | 10163 | 12.285 |
| 03:16 ET | 12325 | 12.26 |
| 03:18 ET | 34321 | 12.195 |
| 03:20 ET | 13153 | 12.195 |
| 03:21 ET | 25975 | 12.205 |
| 03:23 ET | 17162 | 12.19 |
| 03:25 ET | 20885 | 12.19 |
| 03:27 ET | 13797 | 12.175 |
| 03:30 ET | 22786 | 12.22 |
| 03:32 ET | 12495 | 12.21 |
| 03:34 ET | 29068 | 12.195 |
| 03:36 ET | 11098 | 12.205 |
| 03:38 ET | 22712 | 12.2225 |
| 03:39 ET | 22737 | 12.235 |
| 03:41 ET | 36873 | 12.245 |
| 03:43 ET | 18649 | 12.18 |
| 03:45 ET | 41281 | 12.191 |
| 03:48 ET | 20812 | 12.205 |
| 03:50 ET | 36020 | 12.235 |
| 03:52 ET | 30658 | 12.215 |
| 03:54 ET | 90368 | 12.24 |
| 03:56 ET | 70426 | 12.215 |
| 03:57 ET | 68200 | 12.205 |
| 03:59 ET | 666199 | 12.18 |
Aug 4, 2022
Amicus Therapeutics Reports Wider Q2 Net Loss; Net Sales Climb, from 10:53AM ET on Thursday Aug 04, 2022 by MT Newswires
10:53AM ET on Thursday Aug 04, 2022 by MT NewswiresBRIEF-Amicus Therapeutics Reports Q2 2022 Financial Results, from 7:34AM ET on Thursday Aug 04, 2022 by Thomson Reuters
7:34AM ET on Thursday Aug 04, 2022 by Thomson ReutersAmicus Therapeutics Announces Second Quarter 2022 Financial Results, from 7:00AM ET on Thursday Aug 04, 2022 by GlobeNewswire
7:00AM ET on Thursday Aug 04, 2022 by GlobeNewswire
Jul 26, 2022
Amicus Therapeutics to Announce Second Quarter 2022 Financial Results on August 4, 2022, from 7:00AM ET on Tuesday Jul 26, 2022 by GlobeNewswire
7:00AM ET on Tuesday Jul 26, 2022 by GlobeNewswire
Jul 19, 2022
Insider Sell: Amicus Therapeutics, from 5:06PM ET on Tuesday Jul 19, 2022 by MT Newswires
5:06PM ET on Tuesday Jul 19, 2022 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Amicus Therapeutics Inc | 3.4B | -12.4x | --- |
Abcellera Biologics Inc | 3.2B | 17.3x | --- |
Insmed Inc | 3.3B | -7.9x | --- |
Ultragenyx Pharmaceutical Inc | 3.9B | -7.6x | --- |
Genmab A/S | 23.1B | 71.1x | --- |
Fate Therapeutics Inc | 3.2B | -12.7x | --- |
Company Information
Amicus Therapeutics, Inc. is a biotechnology company that is focused on discovering, developing, and delivering medicines for rare diseases. The Company's portfolio is Galafold (migalastat), which is the approved oral precision medicine for people living with Fabry disease. Galafold is designed to bind to and stabilize an endogenous alpha-galactosidase A (alpha-Gal A) enzyme in patients with genetic variants. Migalastat is approved under the trade name Galafold in the United States, European Union, United Kingdom and Japan. Its biologics program in its pipeline is Amicus Therapeutics GAA (AT-GAA), which is a clinical-stage treatment paradigm for Pompe disease. Pompe disease is a lysosomal disorder (LD) from deficiency in an enzyme, GAA. AT-GAA consists of a uniquely engineered rhGAA enzyme, ATB200, or cipaglucosidase alfa, with an optimized carbohydrate structure to enhance lysosomal uptake, administered in combination with AT2221 (miglustat) that functions as an enzyme stabilizer.
Contact Information
- Headquarters
- 3675 Market StreetPHILADELPHIA, PA, United States 19104
- Phone
- 215-921-7600
- Fax
- 609-662-2001
Executives
- Executive Chairman of the Board
- John Crowley
- President, Chief Executive Officer, Chief Operating Officer, Director
- Bradley Campbell
- Chief Financial Officer
- Daphne Quimi
- Chief People Officer
- David Clark
- Chief Legal Officer, Company Secretary
- Ellen Rosenberg
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4B |
|---|---|
Revenue (TTM) | $321.1M |
Shares Outstanding | 280.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.95 |
EPS | $-0.99 |
Book Value | $1.10 |
P/E Ratio | -12.4x |
Price/Sales (TTM) | 10.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -78.08% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
